Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models

Biochemical Journal

Volumn 434, Issue 1, 2011, Pages 25-35

  Dambrot, Cheryl ^a   Passier, Robert ^a   Atsma, Douwe ^a   Mummery, Christine L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac differentiation; Cardiac disease model; Cardiomyocyte; Drug discovery; Pluripotent stem cell; Regenerative medicine

Indexed keywords

DNA; MYOSIN HEAVY CHAIN BETA; POTASSIUM CHANNEL KCNQ1; RETROVIRUS VECTOR; VALPROIC ACID;

BRUGADA SYNDROME; CARDIAC CHANNELOPATHY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL NUCLEUS TRANSPLANTATION; CELL POPULATION; CELL THERAPY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CYTOLOGY; DISEASE COURSE; DNA MODIFICATION; DNA SEQUENCE; DRUG SAFETY; DRUG SCREENING; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; EMBRYONIC STEM CELL; FIBROBLAST; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENETIC ASSOCIATION; HEART DISEASE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LEOPARD SYNDROME; LONG QT SYNDROME; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QT INTERVAL; REGENERATIVE MEDICINE; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SARCOLEMMA; SARCOMERE; SINUS NODE DYSFUNCTION; SOMATIC CELL; SOMATIC CELL THERAPY; TRANSLATIONAL RESEARCH;

CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HEART DISEASES; HUMANS; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS;

EID: 79251554060     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20101707     Document Type: Review

References (119)

1. Evans, M. J. and Kaufman, M. H. (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156
2. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S. and Jones, J. M. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147
3. Krenz, M. and Robbins, J. (2004) Impact of β-myosin heavy chain expression on cardiac function during stress. J. Am. Coll. Cardiol. 44, 2390-2397
4. Braam, S. R., Denning, C., Van Den Brink, S., Kats, P., Hochstenbach, R., Passier, R. and Mummery, C. L. (2008) Improved genetic manipulation of human embryonic stem cells. Nat. Methods 5, 389-392
5. Braam, S. R., Denning, C., Matsa, E., Young, L. E., Passier, R. and Mummery, C. L. (2008) Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification. Nat. Protoc. 3, 1435-1443
6. Braam, S. R., Denning, C. and Mummery, C. L. (2010) Genetic manipulation of human embryonic stem cells in serum and feeder-free media. Methods Mol. Biol. 584, 413-423
7. Bu, L., Jiang, X., Martin-Puig, S., Caron, L., Zhu, S., Shao, Y., Roberts, D. J., Huang, P. L., Domian, I. J. and Chien, K. R. (2009) Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460, 113-117
8. Fischer, Y., Ganic, E., Ameri, J., Xian, X., Johannesson, M. and Semb, H. (2010) NANOG reporter cell lines generated by gene targeting in human embryonic stem cells. PLoS ONE 5, e12533
9. Hockemeyer, D., Soldner, F., Beard, C., Gao, Q., Mitalipova, M., DeKelver, R. C., Katibah, G. E., Amora, R., Boydston, E. A., Zeitler, B. et al. (2009) Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851-857
10. Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y. L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D et al. (2007) Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25, 1298-1306
11. Zou, J., Maeder, M. L., Mali, P., Pruett-Miller, S. M., Thibodeau-Beganny, S., Chou, B. K., Chen, G., Ye, Z., Park, I. H., Daley, G. Q et al. (2009) Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5, 97-110
12. Carvajal-Vergara, X., Sevilla, A., D'Souza, S. L., Ang, Y. S., Schaniel, C., Lee, D. F., Yang, L., Kaplan, A. D., Adler, E. D., Rozov, R. et al. (2010) Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465, 808-812
13. Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flugel, L., Dorn, T., Goedel, A., Hohnke, C., Hofmann, F. et al. (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397-1409
14. Bird, S. D., Doevendans, P. A., van Rooijen, M. A., Brutel, d. l. R., Hassink, R. J., Passier, R. and Mummery, C. L. (2003) The human adult cardiomyocyte phenotype. Cardiovasc. Res. 58, 423-434
15. Passier, R., van Laake, L. W. and Mummery, C. L. (2008) Stem-cell-based therapy and lessons from the heart. Nature 453, 322-329
16. Mummery, C. L., Davis, R. P. and Krieger, J. E. (2010) Challenges in using stem cells for cardiac repair. Sci. Transl. Med. 2, 27ps17
17. Chen, A. E., Egli, D., Niakan, K., Deng, J., Akutsu, H., Yamaki, M., Cowan, C., Fitz-Gerald, C., Zhang, K., Melton, D. A. and Eggan, K. (2009) Optimal timing of inner cell mass isolation increases the efficiency of human embryonic stem cell derivation and allows generation of sibling cell lines. Cell Stem Cell 4, 103-106
18. Mummery, C. L. and Van Den Eijnden-van Raaij, A. J. (1999) Developmental tumours, early differentiation and the transforming growth factor beta superfamily. Int. J. Dev. Biol. 43, 693-709
19. Damjanov, I. and Andrews, P. W. (1983) Ultrastructural differentiation of a clonal human embryonal carcinoma cell line in vitro. Cancer Res. 43, 2190-2198
20. Vallier, L., Touboul, T., Chng, Z., Brimpari, M., Hannan, N., Millan, E., Smithers, L. E., Trotter, M., Rugg-Gunn, P., Weber, A. and Pedersen, R. A. (2009) Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS ONE 4, e6082
21. Tesar, P. J., Chenoweth, J. G., Brook, F. A., Davies, T. J., Evans, E. P., Mack, D. L., Gardner, R. L. and McKay, R. D. (2007) New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196-199
22. Xu, R. H., Sampsell-Barron, T. L., Gu, F., Root, S., Peck, R. M., Pan, G., Yu, J., Antosiewicz-Bourget, J., Tian, S., Stewart, R. and Thomson, J. A. (2008) NANOGis a direct target of TGFβ/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell 3, 196-206
23. Xu, C., Inokuma, M. S., Denham, J., Golds, K., Kundu, P., Gold, J. D. and Carpenter, M. K. (2001) Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19, 971-974
24. Rodin, S., Domogatskaya, A., Strom, S., Hansson, E. M., Chien, K. R., Inzunza, J., Hovatta, O. and Tryggvason, K. (2010) Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat. Biotechnol. 28, 611-615
25. Braam, S. R., Zeinstra, L., Litjens, S., Ward-van Oostwaard, D., Van Den Brink, S., van Laake, L., Lebrin, F., Kats, P., Hochstenbach, R., Passier, R et al. (2008) Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via αVβ5 integrin. Stem Cells 26, 2257-2265
26. Villa-Diaz, L. G., Nandivada, H., Ding, J., Nogueira-de-Souza, N. C., Krebsbach, P. H., O'Shea, K. S., Lahann, J. and Smith, G. D. (2010) Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat. Biotechnol. 28, 581-583
27. Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S. et al. (2006) Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187
28. Vallier, L., Alexander, M. and Pedersen, R. A. (2005) Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118, 4495-4509
29. Lu, J., Hou, R., Booth, C. J., Yang, S. H. and Snyder, M. (2006) Defined culture conditions of human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 103, 5688-5693
30. Liu, Y., Song, Z., Zhao, Y., Qin, H., Cai, J., Zhang, H., Yu, T., Jiang, S., Wang, G., Ding, M. and Deng, H. (2006) A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells. Biochem. Biophys. Res. Commun. 346, 131-139
31. Chen, S., Do, J. T., Zhang, Q., Yao, S., Yan, F., Peters, E. C., Scholer, H. R., Schultz, P. G. and Ding, S. (2006) Self-renewal of embryonic stem cells by a small molecule. Proc. Natl. Acad. Sci. U. S. A. 103, 17266-17271
32. Mollamohammadi, S., Taei, A., Pakzad, M., Totonchi, M., Seifinejad, A., Masoudi, N. and Baharvand, H. (2009) A simple and efficient cryopreservation method for feeder-free dissociated human induced pluripotent stem cells and human embryonic stem cells. Hum. Reprod. 24, 2468-2476
33. Martin-Ibanez, R., Stromberg, A. M., Hovatta, O. and Canals, J. M. (2009) Cryopreservation of dissociated human embryonic stem cells in the presence of ROCK inhibitor. Curr. Protoc. Stem Cell Biol. 1, 1C.8
34. Xu, X., Cowley, S., Flaim, C. J., James, W., Seymour, L. W. and Cui, Z. (2010) Enhancement of cell recovery for dissociated human embryonic stem cells after cryopreservation. Biotechnol. Prog. 26, 781-788
35. Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S., Muguruma, K. and Sasai, Y. (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681-686
36. Gauthaman, K., Fong, C. Y. and Bongso, A. (2010) Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansion. Stem Cell Rev. 6, 86-95
37. Pakzad, M., Totonchi, M., Taei, A., Seifinejad, A., Hassani, S. N. and Baharvand, H. (2010) Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging. Stem Cell Rev. 6, 96-107
38. Braam, S. R., Nauw, R., Ward-van Oostwaard, D., Mummery, C. L. and Passier, R. (2010) Inhibition of ROCK improves survival of human embryonic stem cell-derived cardiomyocytes after dissociation. Ann. N. Y. Acad. Sci. 1188, 52-57
39. Ellerstrom, C., Strehl, R., Noaksson, K., Hyllner, J. and Semb, H. (2007) Facilitated expansion of human embryonic stem cells by single-cell enzymatic dissociation. Stem Cells 25, 1690-1696
40. Olmer, R., Haase, A., Merkert, S., Cui, W., Palecek, J., Ran, C., Kirschning, A., Scheper, T., Glage, S., Miller, K., Curnow, E. C. et al. (2010) Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res. 5, 51-64
41. Singh, H., Mok, P., Balakrishnan, T., Rahmat, S. N. and Zweigerdt, R. (2010) Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res. 4, 165-179
42. Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676
43. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872
44. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R. et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920
45. Wilmut, I., Beaujean, N., de Sousa, P. A., Dinnyes, A., King, T. J., Paterson, L. A., Wells, D. N. and Young, L. E. (2002) Somatic cell nuclear transfer. Nature 419, 583-586
46. Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R. et al. (2007) Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70
47. Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. et al. (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290
48. Polo, J. M., Liu, S., Figueroa, M. E., Kulalert, W., Eminli, S., Tan, K. Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T. et al. (2010) Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28, 848-855
49. Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilic, J., Pekarik, V., Tiscornia, G. et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276-1284
50. Giorgetti, A., Montserrat, N., Aasen, T., Gonzalez, F., Rodriguez-Piza, I., Vassena, R., Raya, A., Boue, S., Barrero, M. J., Corbella, B. A. et al. (2009) Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353-357
51. Haase, A., Olmer, R., Schwanke, K., Wunderlich, S., Merkert, S., Hess, C., Zweigerdt, R., Gruh, I., Meyer, J., Wagner, S. et al. (2009) Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5, 434-441
52. Loh, Y. H., Agarwal, S., Park, I. H., Urbach, A., Huo, H., Heffner, G. C., Kim, K., Miller, J. D., Ng, K. and Daley, G. Q. (2009) Generation of induced pluripotent stem cells from human blood. Blood 113, 5476-5479
53. Ye, Z., Zhan, H., Mali, P., Dowey, S., Williams, D. M., Jang, Y. Y., Dang, C. V., Spivak, J. L., Moliterno, A. R. and Cheng, L. (2009) Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114, 5473-5480
54. Oda, Y., Yoshimura, Y., Ohnishi, H., Tadokoro, M., Katsube, Y., Sasao, M., Kubo, Y., Hattori, K., Saito, S., Horimoto, S. et al. (2010) Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J. Biol. Chem. 285, 29270-29278
55. Miyoshi, K., Tsuji, D., Kudoh, K., Satomura, K., Muto, T., Itoh, K. and Noma, T. (2010) Generation of human induced pluripotent stem cells from oral mucosa. J. Biosci. Bioeng. 110, 345-50
56. Loh, Y. -H., Hartung, O., Li, H., Guo, C., Sahalie, J. M., Manos, P. D., Urbach, A., Heffner, G. C., Grskovic, M., Vigneault, F. et al. (2010) Reprogramming of T-cells from human peripheral blood. Cell Stem Cell 7, 15-19
57. Seki, T., Yuasa, S., Oda, M., Egashira, T., Yae, K., Kusumoto, D., Nakata, H., Tohyama, S., Hashimoto, H., Kodaira, M. et al. (2010) Generation of induced pluripotent stem cells from human terminally differentiated circulating T-cells. Cell Stem Cell 7, 11-14
58. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. and Hochedlinger, K. (2008) Induced pluripotent stem cells generated without viral integration. Science 322, 945-949
59. Zhou, W. and Freed, C. R. (2009) Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27, 2667-2674
60. Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hamalainen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M. et al. (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766-770
61. Si-Tayeb, K., Noto, F. K., Sepac, A., Sedlic, F., Bosnjak, Z. J., Lough, J. W. and Duncan, S. A. (2010) Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC. Dev. Biol. 10, 81
62. Angel, M. and Yanik, M. F. (2010) Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS ONE 5, e11756
63. Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W. and Melton, D. A. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26, 1269-1275
64. Yoshida, Y. and Yamanaka, S. (2010) Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation 122, 80-87
65. Yamanaka, S. and Blau, H. M. (2010) Nuclear reprogramming to a pluripotent state by three approaches. Nature 465, 704-712
66. Leeper, N. J., Hunter, A. L. and Cooke, J. P. (2010) Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation 122, 517-526
67. Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz-Eldor, J. and Gepstein, L. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest 108, 407-414
68. Mohr, J. C., Zhang, J., Azarin, S. M., Soerens, A. G., de Pablo, J. J., Thomson, J. A., Lyons, G. E., Palecek, S. P. and Kamp, T. J. (2010) The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells. Biomaterials 31, 1885-1893
69. Boheler, K. R., Czyz, J., Tweedie, D., Yang, H. T., Anisimov, S. V. and Wobus, A. M. (2002) Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ. Res. 91, 189-201
70. Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I. H. and Gepstein, L. (2009) Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120, 1513-1523
71. Mummery, C., Van Der Heyden, M. A., de Boer, T. P., Passier, R., Ward, D., Van Den Brink, S., van Rooijen, M. and van de Stolpe, A. (2007) Cardiomyocytes from human and mouse embryonic stem cells. Methods Mol. Med. 140, 249-272
72. Passier, R., Denning, C. and Mummery, C. (2006) Cardiomyocytes from human embryonic stem cells. Handb. Exp. Pharmacol. 174, 101-122
73. Yoon, B. S., Yoo, S. J., Lee, J. E., You, S., Lee, H. T. and Yoon, H. S. (2006) Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation 74, 149-159
74. Ng, E. S., Davis, R. P., Azzola, L., Stanley, E. G. and Elefanty, A. G. (2005) Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood 106, 1601-1603
75. Ng, E. S., Davis, R., Stanley, E. G. and Elefanty, A. G. (2008) A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat. Protoc. 3, 768-776
76. Filipczyk, A. A., Passier, R., Rochat, A. and Mummery, C. L. (2007) Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Cell Mol. Life Sci. 64, 704-718
77. Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M. et al. (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453, 524-528
78. Gaur, M., Ritner, C., Sievers, R., Pedersen, A., Prasad, M., Bernstein, H. S. and Yeghiazarians, Y. (2010) Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes. Cytotherapy 12, 807-817
79. Graichen, R., Xu, X., Braam, S. R., Balakrishnan, T., Norfiza, S., Sieh, S., Soo, S. Y., Tham, S. C., Mummery, C., Colman, A. et al. (2008) Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 76, 357-370
80. Sadek, H., Hannack, B., Choe, E., Wang, J., Latif, S., Garry, M. G., Garry, D. J., Longgood, J., Frantz, D. E., Olson, E. N. et al. (2008) Cardiogenic small molecules that enhance myocardial repair by stem cells. Proc. Natl. Acad. Sci. U. S. A. 105, 6063-6068
81. + cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell 1, 165-179
82. Hao, J., Daleo, M. A., Murphy, C. K., Yu, P. B., Ho, J. N., Hu, J., Peterson, R. T., Hatzopoulos, A. K. and Hong, C. C. (2008) Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS ONE 3, e2904
83. Freund, C., Ward-van Oostwaard, D., Monshouwer-Kloots, J., van den Brink, S., van Rooijen, M., Xu, X., Zweigerdt, R., Mummery, C. and Passier, R. (2008) Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells. Stem Cells 26, 724-733
84. Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker, R., Van Den Brink, S., Hassink, R., van der Heyden, M., Opthof, T., Pera, M., de la Riviere, A. B. et al. (2003) Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107, 2733-2740
85. Passier, R., Oostwaard, D. W., Snapper, J., Kloots, J., Hassink, R. J., Kuijk, E., Roelen, B., de la Riviere, A. B. and Mummery, C. (2005) Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 23, 772-780
86. Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S. et al. (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015-1024
87. Otsuji, T. G., Minami, I., Kurose, Y., Yamauchi, K., Tada, M. and Nakatsuji, N. (2010) Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: qualitative effects on electrophysiological responses to drugs. Stem Cell Res. 4, 201-213
88. Salameh, A., Wustmann, A., Karl, S., Blanke, K., Apel, D., Rojas-Gomez, D., Franke, H., Mohr, F. W., Janousek, J. and Dhein, S. (2010) Cyclic mechanical stretch induces cardiomyocyte orientation and polarization of the gap junction protein connexin43. Circ. Res. 106, 1592-1602
89. Zhu, W. Z., Xie, Y., Moyes, K. W., Gold, J. D., Askari, B. and Laflamme, M. A. (2010) Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ. Res. 107, 776-786
90. Anderson, D., Self, T., Mellor, I. R., Goh, G., Hill, S. J. and Denning, C. (2007) Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol. Ther. 15, 2027-2036
91. Huber, I., Itzhaki, I., Caspi, O., Arbel, G., Tzukerman, M., Gepstein, A., Habib, M., Yankelson, L., Kehat, I. and Gepstein, L. (2007) Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J. 21, 2551-2563
92. Xu, X. Q., Zweigerdt, R., Soo, S. Y., Ngoh, Z. X., Tham, S. C., Wang, S. T., Graichen, R., Davidson, B., Colman, A. and Sun, W. (2008) Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy 10, 376-389
93. Xu, C., Police, S., Hassanipour, M. and Gold, J. D. (2006) Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev. 15, 631-639
94. Hattori, F., Chen, H., Yamashita, H., Tohyama, S., Satoh, Y. S., Yuasa, S., Li, W., Yamakawa, H., Tanaka, T., Onitsuka, T. et al. (2010) Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat. Methods 7, 61-66
95. Braam, S. R., Tertoolen, L., van de Stolpe, A., Meyer, T., Passier, R. and Mummery, C. L. (2010) Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 4, 107-116
96. Amit, M., Carpenter, M. K., Inokuma, M. S., Chiu, C. P., Harris, C. P., Waknitz, M. A., Itskovitz-Eldor, J. and Thomson, J. A. (2000) Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271-278
97. Eiges, R., Schuldiner, M., Drukker, M., Yanuka, O., Itskovitz-Eldor, J. and Benvenisty, N. (2001) Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr. Biol. 11, 514-518
98. Maeder, M. L., Thibodeau-Beganny, S., Osiak, A., Wright, D. A., Anthony, R. M., Eichtinger, M., Jiang, T., Foley, J. E., Winfrey, R. J., Townsend, J. A. et al. (2008) Rapid 'open-source' engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol. Cell 31, 294-301
99. Sakurai, K., Shimoji, M., Tahimic, C. G., Aiba, K., Kawase, E., Hasegawa, K., Amagai, Y., Suemori, H. and Nakatsuji, N. (2010) Efficient integration of transgenes into a defined locus in human embryonic stem cells. Nucleic Acids Res. 38, e96
100. Anastassiadis, K., Fu, J., Patsch, C., Hu, S., Weidlich, S., Duerschke, K., Buchholz, F., Edenhofer, F. and Stewart, A. F. (2009) Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Dis. Model Mech. 2, 508-515
101. Wilber, A., Linehan, J. L., Tian, X., Woll, P. S., Morris, J. K., Belur, L. R., McIvor, R. S. and Kaufman, D. S. (2007) Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells 25, 2919-2927
102. Lacoste, A., Berenshteyn, F. and Brivanlou, A. H. (2009) An efficient and reversible transposable system for gene delivery and lineage-specific differentiation in human embryonic stem cells. Cell Stem Cell 5, 332-342
103. Paatero, A. O., Turakainen, H., Happonen, L. J., Olsson, C., Palomaki, T., Pajunen, M. I., Meng, X., Otonkoski, T., Tuuri, T., Berry, C., Malani, N. et al. (2008) Bacteriophage Mu integration in yeast and mammalian genomes. Nucleic Acids Res. 36, e148
104. Nieminen, M., Tuuri, T. and Savilahti, H. (2010) Genetic recombination pathways and their application for genome modification of human embryonic stem cells. Exp. Cell Res. 316, 2578-2586
105. Priori, S. G. and Napolitano, C. (2006) Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies. Circulation 113, 1130-1135
106. Maron, B. J. (1997) Hypertrophic cardiomyopathy. Lancet 350, 127-133
107. Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A. and Kamp, T. J. (2009) Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30-e41
108. Freund, C., Davis, R. P., Gkatzis, K., Ward-van Oostwaard, D. and Mummery, C. L. (2010) The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands. Neth. Heart J. 18, 51-54
109. Ieda, M., Fu, J. D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G. and Srivastava, D. (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386
110. Murry, C. E., Soonpaa, M. H., Reinecke, H., Nakajima, H., Nakajima, H. O., Rubart, M., Pasumarthi, K. B., Virag, J. I., Bartelmez, S. H., Poppa, V. et al. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428, 664-668
111. Balsam, L. B., Wagers, A. J., Christensen, J. L., Kofidis, T., Weissman, I. L. and Robbins, R. C. (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428, 668-673
112. Nygren, J. M., Jovinge, S., Breitbach, M., Sawen, P., Roll, W., Hescheler, J., Taneera, J., Fleischmann, B. K. and Jacobsen, S. E. (2004) Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10, 494-501
113. van Ramshorst, J., Bax, J. J., Beeres, S. L., Dibbets-Schneider, P., Roes, S. D., Stokkel, M. P., de Roos, A., Fibbe, W. E., Zwaginga, J. J., Boersma, E., Schalij, M. J. and Atsma, D. E. (2009) Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. J. Am. Med. Assoc. 301, 1997-2004
114. Dai, W., Field, L. J., Rubart, M., Reuter, S., Hale, S. L., Zweigerdt, R., Graichen, R. E., Kay, G. L., Jyrala, A. J. et al. (2007) Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J. Mol. Cell Cardiol. 43, 504-516
115. Gepstein, L., Ding, C., Rehemedula, D., Wilson, E. E., Yankelson, L., Caspi, O., Gepstein, A., Huber, I. and Olgin, J. E. (2010) In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells, doi:10.1002/stem.545
116. van Laake, L. W., Passier, R., Monshouwer-Kloots, J., Verkleij, A. J., Lips, D. J., Freund, C., den Ouden, K., Ward-van Oostwaard, D., Korving, J., Tertoolen, L. G. et al. (2007) Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 1, 9-24 (Pubitemid 350251944)
117. Lambert, V, Capderour, A, Gouadon, E, Rucker-Martin, C, Dinanian, S, Stos, B, Puceat, M, Serraf, A. and Renaud, J. F. (2010) Cell therapy using cardiac-committed human embryonic stem cells improves right ventricular function in a porcine model of chronic overload: first promising results. Eur. Heart J. 31,
118. Strauss, S. (2010) Geron trial resumes, but standards for stem cell trials remain elusive. Nat. Biotechnol. 28, 989-990
119. Van, H. D., D'Amour, K. A. and German, M. S. (2009) Derivation of insulin-producing cells from human embryonic stem cells. Stem Cell Res. 3, 73-87